Hepatitis C virus–related factors associated WITH cognitive performance in HIV-HCV-coinfected patients

Liver fibrosis is associated with cognitive impairment in people living with HIV

(2019) Nicoletta Ciccarelli et al.   INFECTION

In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition

(2018) Tiziana Latronico et al.   JOURNAL OF NEUROCHEMISTRY

Brief Report

(2017) Massimiliano Fabbiani et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Tolerability of integrase inhibitors in a real-life setting

(2017) Judit Peñafiel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Differential Effects of Antiretroviral Drugs on Neurons In Vitro: Roles for Oxidative Stress and Integrated Stress Response

(2017) Anna L. Stern et al.   Journal of Neuroimmune Pharmacology

Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice

(2016) Mark G.J. de Boer et al.   AIDS

Case control study: magnetic resonance spectroscopy of brain in HIV infected patients

(2016) Devender Bairwa et al.   BMC Neurology

Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C

(2016) Victor G. Valcour et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Liver fibrosis progression and clinical outcomes are intertwined

(2016) Emanuele Focà et al.   MEDICINE

Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics

(2016) Ankit Shah et al.   NEUROTOXICITY RESEARCH

Diabetes and cognitive decline in a French cohort of patients infected with HIV-1

(2015) Carole Dufouil et al.   NEUROLOGY

Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility

(2014) Massimiliano Fabbiani et al.   ANTIVIRAL THERAPY

Baseline CD4+ T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients

(2014) Nicoletta Ciccarelli et al.   ANTIVIRAL THERAPY

Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system

(2014) Cagla Akay et al.   JOURNAL OF NEUROVIROLOGY

Comparison of cognitive performance in HIV or HCV mono-infected and HIV–HCV co-infected patients

(2013) N. Ciccarelli et al.   INFECTION

Raltegravir central nervous system tolerability in clinical practice

(2012) Giordano Madeddu et al.   AIDS

Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care

(2012) JA McCombe et al.   HIV MEDICINE

Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients

(2012) M Fabbiani et al.   HIV MEDICINE

Antiretroviral neurotoxicity

(2012) Kevin Robertson et al.   JOURNAL OF NEUROVIROLOGY

Effect of Aging and Human Immunodeficiency Virus Infection on Cognitive Abilities

(2012) Nicoletta Ciccarelli et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

(2011) Ronald J. Ellis et al.   AIDS

Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS

(2011) Pornpun Vivithanaporn et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients

(2011) N. Ciccarelli et al.   NEUROLOGY

Practice effects in healthy adults: A longitudinal study on frequent repetitive cognitive testing

(2010) Claudia Bartels et al.   BMC NEUROSCIENCE

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

(2010) R. K. Heaton et al.   NEUROLOGY

Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients

(2009) D. B. Clifford et al.   NEUROLOGY